Structures by: Thiruvalluvar A.
Total: 151
(<i>E</i>)-4-Iodo-2-[(phenylimino)methyl]phenol
C13H10INO
IUCrData (2019) 4, 6
a=7.0848(8)Å b=26.422(3)Å c=6.2664(7)Å
α=90° β=90° γ=90°
(4-Methylphenyl)methanaminium bromide hemihydrate
C8H12N1,Br,0.5H2O
IUCrData (2018) 3, 2 x180270
a=30.7456(18)Å b=5.0266(3)Å c=12.0636(7)Å
α=90° β=98.430(2)° γ=90°
1-Carboxy-2-hydroxypropan-1-aminium 4-methylbenzenesulfonate monohydrate
C4H10NO3,C7H7O3S,H2O
IUCrData (2018) 3, 1 x171848
a=8.0762(4)Å b=6.2486(4)Å c=14.5096(10)Å
α=90° β=92.161(2)° γ=90°
C14H13NO
C14H13NO
IUCrData (2018) 3, 3 x180464
a=4.6976(4)Å b=19.3656(18)Å c=12.3116(12)Å
α=90° β=95.831(3)° γ=90°
T(3)-Benzyl-r(2),c(6)-diphenylpiperidin-4-one oxime
C24H24N2O
IUCrData (2016) 1, 12 x161982
a=19.5024(9)Å b=8.7503(4)Å c=11.6500(6)Å
α=90° β=100.846(2)° γ=90°
4-Methylbenzylammonium chloride hemihydrate
C8H12N,Cl,0.5(H2O)
IUCrData (2017) 2, 8 x171213
a=30.5325(14)Å b=4.8966(2)Å c=11.8973(5)Å
α=90° β=99.067(2)° γ=90°
(<i>E</i>)-4-Nitro-2-[(phenylimino)methyl]phenol
C13H10N2O3
IUCrData (2016) 1, 10 x161595
a=8.0774(10)Å b=6.5801(6)Å c=21.668(3)Å
α=90° β=98.240(5)° γ=90°
3-Chloro-<i>r</i>-2,<i>c</i>-6-bis(4-fluorophenyl)-3-methylpiperidin-4-one
C18H16ClF2NO
IUCrData (2016) 1, 10 x161580
a=6.2844(2)Å b=11.7141(5)Å c=21.6006(10)Å
α=90° β=90° γ=90°
Benzylammonium nitrate
C8H12NO,NO3
IUCrData (2017) 2, 8 x171114
a=15.8203(17)Å b=6.8156(7)Å c=8.7275(8)Å
α=90° β=90° γ=90°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C18H18ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=6.7150(6)Å b=10.9591(13)Å c=11.1704(10)Å
α=72.162(9)° β=79.721(7)° γ=76.873(8)°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-di-<i>p</i>-tolylpiperidin-4-one
C20H22ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.0578(2)Å b=22.6513(4)Å c=5.93756(8)Å
α=90° β=90° γ=90°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-bis(4-chlorophenyl)piperidin-4-one
C18H16Cl3NO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.2430(4)Å b=22.3945(6)Å c=5.81947(14)Å
α=90° β=90° γ=90°
3-(2-Chloroethyl)-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C19H20ClNO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=11.3306(3)Å b=13.3638(4)Å c=10.9821(3)Å
α=90° β=91.996(2)° γ=90°
3-(2-chloroethyl)-<i>r</i>-2,<i>c</i>-6-bis(4-fluorophenyl)piperidin-4-one
C19H18ClF2NO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=5.5105(2)Å b=24.2612(6)Å c=12.8622(3)Å
α=90° β=93.809(3)° γ=90°
(<i>E</i>)-2-(Furan-2-ylmethylidene)-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-one
C17H13NO2
Acta Crystallographica Section E (2018) 74, 1 59-61
a=15.353(3)Å b=6.3143(13)Å c=26.941(6)Å
α=90° β=96.446(4)° γ=90°
Chalcone
C22H17NO3
Acta Crystallographica Section E (2015) 71, 1 o65-o66
a=17.8214(10)Å b=6.1630(3)Å c=32.3569(19)Å
α=90° β=103.165(2)° γ=90°
Benzimidazole
C13H10N2O
Acta Crystallographica Section E (2014) 70, 2 o184
a=16.864(4)Å b=4.7431(8)Å c=12.952(2)Å
α=90° β=102.34(2)° γ=90°
Pentane-1,5-diol
C26H30O2
Acta Crystallographica Section E (2014) 70, 2 o122-o123
a=14.6205(5)Å b=14.6205(5)Å c=20.2672(6)Å
α=90° β=90° γ=120°
1,5-diketone
C24H20Cl2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 10 o1508-9
a=18.6794(11)Å b=7.5477(4)Å c=15.5196(8)Å
α=90° β=103.622(5)° γ=90°
Carbazole
C23H14N2O2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o831
a=7.86590(10)Å b=8.51510(10)Å c=25.1137(4)Å
α=90° β=98.133(2)° γ=90°
Carbazole
C20H15N3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 5 o801
a=12.0727(6)Å b=7.5934(3)Å c=16.8355(8)Å
α=90° β=104.087(5)° γ=90°
Carbazole
C18H15NO2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o150
a=6.3925(3)Å b=7.9880(4)Å c=13.8629(8)Å
α=83.151(5)° β=81.649(4)° γ=78.921(4)°
Benzimidazole
C19H14N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 1 o62
a=8.1941(6)Å b=9.5983(14)Å c=10.3193(18)Å
α=64.637(16)° β=80.356(10)° γ=83.610(9)°
Chalcone
C22H18O
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 7 o809-10
a=7.6396(3)Å b=9.9106(4)Å c=11.9263(4)Å
α=103.166(2)° β=104.713(2)° γ=103.308(2)°
Piperidine-4-one
C17H19NO4
Acta Crystallographica Section E (2006) 62, 5 o2005-o2006
a=8.036(4)Å b=8.5608(15)Å c=22.180(7)Å
α=90° β=91.05(3)° γ=90°
C10H8O2
C10H8O2
Acta Crystallographica Section E (2003) 59, 4 o395-o396
a=8.3865(13)Å b=18.273(4)Å c=10.652(2)Å
α=90° β=90° γ=90°
Imidazoacethydrazone
C15H17N5O3
Acta Crystallographica Section E (2006) 62, 3 o1126-o1128
a=8.423(2)Å b=10.577(4)Å c=17.97(3)Å
α=90° β=89.46(8)° γ=90°
C14H14ClNO
C14H14ClNO
Acta Crystallographica Section E (2001) 57, 12 o1240-o1241
a=11.782(4)Å b=10.288(3)Å c=20.461(3)Å
α=90° β=100.20(2)° γ=90°
C10H20N2Ni1S4
C10H20N2Ni1S4
Acta Crystallographica Section C (1995) 51, 4 606-608
a=6.179(1)Å b=11.534(1)Å c=11.609(2)Å
α=90.° β=95.79(1)° γ=90.°
1-Cyano-2-(2,3,6,7-tetramethoxy-10-diethylaminomethylphenanthr-9-yl)pyrrolidine
C29H37N3O4
Acta Crystallographica Section C (1995) 51, 10 2189-2192
a=12.563(3)Å b=14.083(4)Å c=15.308(3)Å
α=90.00° β=102.17(2)° γ=90.00°
C22H23NO2
C22H23NO2
Acta Crystallographica Section C (1995) 51, 12 2641-2643
a=10.001(1)Å b=20.603(2)Å c=8.601(1)Å
α=90° β=90° γ=90°
C16H22N2O
C16H22N2O
Acta Crystallographica Section C (1996) 52, 12 3177-3179
a=7.6940(1)Å b=11.1350(1)Å c=17.6949(1)Å
α=90° β=101.62(1)° γ=90°
C20H24N2O1
C20H24N2O1
Acta Crystallographica Section C (1994) 50, 5 827-829
a=5.903(2)Å b=11.143(5)Å c=13.912(4)Å
α=77.72(3)° β=82.83(2)° γ=83.12(3)°
Trans-decahydroquinoline
C17H22N2O2
Acta Crystallographica Section C (1997) 53, 8 1086-1088
a=7.596(2)Å b=22.882(11)Å c=9.311(2)Å
α=90.00° β=110.18(2)° γ=90.00°
C19H25NO2
C19H25NO2
Acta Crystallographica Section C (1996) 52, 6 1563-1565
a=10.683(2)Å b=16.996(5)Å c=18.770(3)Å
α=90° β=90° γ=90°
Pyrazolocarbazole
C15H13N3O2,C2H4O2
Acta Crystallographica Section E (2007) 63, 5 o2729-o2730
a=7.1379(2)Å b=11.0450(4)Å c=11.5179(4)Å
α=117.2520(10)° β=100.046(2)° γ=95.486(2)°
Tetrahydrocarbazole
C15H15NO3
Acta Crystallographica Section E (2007) 63, 5 o2413-o2414
a=4.6362(6)Å b=10.7289(14)Å c=13.4557(18)Å
α=69.665(7)° β=88.411(9)° γ=88.287(8)°
Phenylcyclohexanone
C14H14N2O3
Acta Crystallographica Section E (2007) 63, 5 o2717-o2717
a=12.2284(3)Å b=8.0986(3)Å c=13.1376(4)Å
α=90° β=91.336(2)° γ=90°
Pyrimidine derivative
C16H13ClN4O
Acta Crystallographica Section E (2007) 63, 6 o2911-o2911
a=7.2458(2)Å b=13.6704(4)Å c=14.4757(3)Å
α=90.718(2)° β=92.618(2)° γ=93.6230(10)°
Di-2-furylpiperidin-4-one
C20H19NO3
Acta Crystallographica Section E (2007) 63, 6 o2910-o2910
a=5.443(5)Å b=21.437(5)Å c=14.108(5)Å
α=90° β=91.037(5)° γ=90°
Diphenylpiperidin-4-ol
C19H23NO
Acta Crystallographica Section E (2007) 63, 6 o2886-o2886
a=11.6611(3)Å b=12.4948(4)Å c=12.0089(3)Å
α=90° β=117.3080(10)° γ=90°
Substituted-carbazole
C15H15NO3
Acta Crystallographica Section E (2007) 63, 7 o3093-o3093
a=9.1267(3)Å b=8.2114(3)Å c=17.2304(9)Å
α=90° β=91.151(4)° γ=90°
Diphenylpiperidin-4-one
C19H21NO
Acta Crystallographica Section E (2007) 63, 8 o3504-o3504
a=7.1392(3)Å b=10.5811(5)Å c=11.6276(5)Å
α=102.320(2)° β=107.613(2)° γ=101.735(2)°
Isoxazolocarbazole
C15H12N2O
Acta Crystallographica Section E (2007) 63, 8 o3631-o3631
a=23.640(2)Å b=5.0840(5)Å c=19.2139(19)Å
α=90° β=93.974(10)° γ=90°
Pyrimidine derivative
C14H9BrN4O
Acta Crystallographica Section E (2007) 63, 8 o3362-o3362
a=15.1590(3)Å b=6.4761(2)Å c=13.1979(3)Å
α=90° β=90.584(2)° γ=90°
Pyrimidine derivative
C14H19N5O2S2
Acta Crystallographica Section E (2007) 63, 8 o3425-o3425
a=7.1250(3)Å b=10.6735(3)Å c=12.3740(5)Å
α=93.607(2)° β=90.561(2)° γ=107.474(2)°
Substituted carbazole
C14H13NO3
Acta Crystallographica Section E (2007) 63, 8 o3622-o3622
a=6.9814(12)Å b=8.1303(13)Å c=10.780(2)Å
α=88.575(14)° β=76.881(15)° γ=79.367(14)°
Methyl-carbazole
C13H13NO
Acta Crystallographica Section E (2007) 63, 8 o3524-o3524
a=7.4974(5)Å b=14.9690(11)Å c=8.9885(10)Å
α=90° β=90° γ=90°
Benzodiazepine
C19H23N3O
Acta Crystallographica Section E (2007) 63, 11 o4264-o4264
a=6.60100(10)Å b=13.8353(2)Å c=37.7572(6)Å
α=90° β=90° γ=90°
Cis-2-(p-Fluoro)phenyl-6-phenyldithian-4-one 1-oxide
C17H14FO2S
Acta Crystallographica Section E (2007) 63, 11 o4486-o4486
a=11.3887(5)Å b=24.6558(14)Å c=5.1828(2)Å
α=90° β=90° γ=90°
Piperidine derivative
C20H21Cl2NO
Acta Crystallographica Section E (2007) 63, 11 o4482-o4482
a=17.3013(7)Å b=8.3742(4)Å c=12.3687(5)Å
α=90° β=98.647(4)° γ=90°
4-Hydroxyimino-2-phenylperhydroquinolinium chloride hemihydrate
C15H21N2O,Cl,0.5H2O
Acta Crystallographica Section E (2007) 63, 11 o4431-o4431
a=13.1733(4)Å b=18.2824(5)Å c=12.6656(4)Å
α=90° β=90° γ=90°
2-Chloro-3-methylquinoxaline
C9H7ClN2
Acta Crystallographica Section E (2007) 63, 12 o4534-o4534
a=6.8876(4)Å b=7.4022(4)Å c=9.4124(5)Å
α=70.654(4)° β=72.438(5)° γ=65.019(5)°
Pyrazole
C18H17N3O3S
Acta Crystallographica Section E (2007) 63, 12 o4770-o4770
a=5.2630(2)Å b=35.631(2)Å c=9.0145(3)Å
α=90° β=91.651(4)° γ=90°
Piperidone
C25H23NO2
Acta Crystallographica Section E (2007) 63, 12 o4533-o4533
a=10.5355(3)Å b=9.3464(2)Å c=21.0493(5)Å
α=90° β=101.520(3)° γ=90°
1,2,3-triazole
C15H11F3N4O
Acta Crystallographica Section E (2007) 63, 12 o4813-o4814
a=11.7974(4)Å b=8.2946(2)Å c=14.6706(4)Å
α=90° β=106.273(3)° γ=90°
Chalcone
C16H13ClOS
Acta Crystallographica Section E (2007) 63, 12 o4716-o4716
a=16.5150(10)Å b=14.3026(9)Å c=5.7280(3)Å
α=90° β=91.284(5)° γ=90°
Piperidine derivative
C20H15Cl2N3
Acta Crystallographica Section E (2007) 63, 12 o4853-o4853
a=15.1732(10)Å b=7.5493(5)Å c=16.3452(12)Å
α=90° β=105.494(7)° γ=90°
Thiopyran
C22H20N2O2S
Acta Crystallographica Section E (2007) 63, 10 o4149-o4149
a=8.4906(3)Å b=24.6848(7)Å c=9.4361(4)Å
α=90° β=90° γ=90°
1,2,4-triazole
C18H10F3N5O2
Acta Crystallographica Section E (2007) 63, 12 o4867-o4868
a=8.0065(2)Å b=16.9010(4)Å c=12.0204(3)Å
α=90° β=92.633(2)° γ=90°
Pyrimidine derivative
C14H10Br2N6O
Acta Crystallographica Section E (2008) 64, 2 o362-o362
a=9.1647(3)Å b=12.2833(5)Å c=14.0288(5)Å
α=86.532(3)° β=84.218(3)° γ=78.747(3)°
Piperidin-4-one
C20H20Cl2N2O2
Acta Crystallographica Section E (2008) 64, 10 o1973
a=8.2771(2)Å b=11.1921(4)Å c=11.2351(4)Å
α=93.375(3)° β=106.924(3)° γ=104.549(3)°
Pyrimidine derivative
C10H10BrN5O2
Acta Crystallographica Section E (2007) 63, 12 o4535-o4535
a=6.3433(3)Å b=28.9030(8)Å c=6.9439(3)Å
α=90° β=109.821(5)° γ=90°
Piperidine derivative
C21H25NO2
Acta Crystallographica Section E (2007) 63, 12 o4826-o4826
a=14.4091(5)Å b=12.8347(4)Å c=10.1715(4)Å
α=90° β=99.584(4)° γ=90°
Cyclohex-2-enone derivative
C19H18O2
Acta Crystallographica Section E (2008) 64, 6 o1020
a=9.6002(3)Å b=17.1594(7)Å c=17.6730(5)Å
α=90° β=90° γ=90°
3-Methyl-5-(4-methylphenyl)cyclohex-2-enone
C14H16O
Acta Crystallographica Section E (2008) 64, 6 o1066
a=5.2623(3)Å b=11.1583(7)Å c=19.3341(11)Å
α=90° β=94.994(4)° γ=90°
Cyclohexane derivative
C14H14ClNO
Acta Crystallographica Section E (2008) 64, 6 o1006
a=23.3358(6)Å b=6.0031(2)Å c=20.8948(6)Å
α=90° β=122.386(2)° γ=90°
2-(2-Chlorophenyl)-4,5-diphenyl-1H-imidazole
C21H15ClN2
Acta Crystallographica Section E (2007) 63, 4 o1650-o1652
a=9.0505(2)Å b=10.9501(3)Å c=18.0232(5)Å
α=81.763(2)° β=80.146(2)° γ=77.499(2)°
2,6-Diphenyl-piperidine
C25H22N2
Acta Crystallographica Section E (2007) 63, 6 o2903-o2903
a=7.5687(3)Å b=11.3610(5)Å c=12.1481(5)Å
α=111.318(2)° β=92.757(2)° γ=97.920(2)°
Chalcone
C13H9FOS
Acta Crystallographica Section E (2007) 63, 12 o4536-o4536
a=12.9010(4)Å b=5.82790(10)Å c=14.5705(5)Å
α=90° β=94.505(3)° γ=90°
Chalcone
C16H11Cl3O
Acta Crystallographica Section E (2008) 64, 1 o60-o60
a=7.6432(4)Å b=10.5118(4)Å c=36.2356(12)Å
α=90° β=90° γ=90°
Piperidin-4-one
C15H17NO3
Acta Crystallographica Section E (2008) 64, 1 o59-o59
a=5.1620(2)Å b=20.2855(9)Å c=12.9825(5)Å
α=90° β=91.128(3)° γ=90°
7,8,9,10-Tetrahydrocyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C13H13NO
Acta Crystallographica Section E (2008) 64, 9 o1697
a=14.0914(4)Å b=8.0883(2)Å c=9.2503(3)Å
α=90° β=108.937(3)° γ=90°
Carbazol derivative
C13H13NO2
Acta Crystallographica Section E (2008) 64, 4 o763-o764
a=9.0627(2)Å b=14.0285(3)Å c=8.5506(2)Å
α=90° β=101.8150(10)° γ=90°
Chalcone
C16H14OS
Acta Crystallographica Section E (2008) 64, 7 o1263
a=5.6106(4)Å b=7.6239(7)Å c=30.477(2)Å
α=90° β=90° γ=90°
Piperidin-4-one derivative
C26H27NO3
Acta Crystallographica Section E (2008) 64, 7 o1181
a=5.5612(2)Å b=13.8097(5)Å c=14.5119(6)Å
α=71.629(2)° β=79.928(2)° γ=82.526(2)°
Piperidin-4-one Oxime
C26H28N2O3
Acta Crystallographica Section E (2008) 64, 7 o1211
a=10.2472(4)Å b=11.2723(4)Å c=38.4188(15)Å
α=90° β=90° γ=90°
9H-carbazole
C14H11NO2
Acta Crystallographica Section E (2007) 63, 5 o2682-o2683
a=12.1859(6)Å b=6.6703(3)Å c=14.1899(7)Å
α=90° β=113.469(2)° γ=90°
Cyclohexanone Oxime
C14H16N2O
Acta Crystallographica Section E (2007) 63, 6 o2780-o2780
a=6.6394(2)Å b=14.6658(5)Å c=12.6653(3)Å
α=90° β=95.146(2)° γ=90°
Bis-(2'-furyl)piperidin-4-one
C21H19NO4
Acta Crystallographica Section E (2007) 63, 6 o2909-o2909
a=20.5162(5)Å b=8.9727(3)Å c=19.0466(6)Å
α=90° β=91.395(2)° γ=90°
Piperidone
C17H19NO4
Acta Crystallographica Section E (2007) 63, 2 o789-o791
a=9.1342(7)Å b=15.7260(10)Å c=11.1749(8)Å
α=90° β=103.055(3)° γ=90°
Heterofused carbazole
C15H9NO3
Acta Crystallographica Section E (2007) 63, 5 o2410-o2412
a=6.811(2)Å b=8.751(2)Å c=10.066(4)Å
α=111.84(3)° β=100.31(3)° γ=91.98(3)°
Cyclohexanone
C14H15NO
Acta Crystallographica Section E (2007) 63, 5 o2715-o2716
a=11.5745(3)Å b=17.5499(5)Å c=11.2629(3)Å
α=90° β=90° γ=90°
Pyrazolocarbazole
C15H13N3
Acta Crystallographica Section E (2007) 63, 8 o3471-o3471
a=11.6553(8)Å b=5.7418(3)Å c=18.0804(12)Å
α=90° β=101.796(6)° γ=90°
Oxazole
C12H15NO2
Acta Crystallographica Section E (2008) 64, 1 o61-o61
a=8.1495(2)Å b=10.9369(3)Å c=12.0864(3)Å
α=90° β=91.305(3)° γ=90°
2,6--Diphenyl--piperidine
C27H24N2O
Acta Crystallographica Section E (2008) 64, 5 o797
a=9.4034(17)Å b=10.646(6)Å c=10.8860(18)Å
α=90.45(2)° β=99.957(14)° γ=101.98(3)°
Cyclohexane derivative
C15H17NO
Acta Crystallographica Section E (2008) 64, 5 o818
a=23.4475(5)Å b=6.03700(10)Å c=21.0740(5)Å
α=90° β=123.2670(10)° γ=90°
Carbazol derivative
C12H10ClNO
Acta Crystallographica Section E (2008) 64, 8 o1635
a=10.4211(5)Å b=5.6851(3)Å c=17.0824(10)Å
α=90° β=100.239(6)° γ=90°
Chalcone
C16H13FOS
Acta Crystallographica Section E (2008) 64, 11 o2118-o2119
a=29.7846(9)Å b=5.7070(3)Å c=7.7071(4)Å
α=90° β=90.781(3)° γ=90°
Chalcone
C21H15NO3
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o119
a=17.6546(5)Å b=6.1464(2)Å c=30.0234(9)Å
α=90° β=99.899(4)° γ=90°
C14H15NO
C14H15NO
Acta Crystallographica Section C (1994) 50, 11 1812-1814
a=12.456(8)Å b=6.279(2)Å c=14.409(3)Å
α=90.° β=92.19(3)° γ=90.°
Chalcone
C22H17NO4
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 1 1
a=10.1924(3)Å b=10.8732(3)Å c=16.9675(6)Å
α=97.926(2)° β=93.711(2)° γ=107.729(2)°
Dihydropyrimidine
C14H16N2O2S
Acta Crystallographica Section E (2009) 65, 12 o3036
a=12.0415(2)Å b=6.22190(10)Å c=18.0192(3)Å
α=90° β=100.9010(10)° γ=90°
Dihydropyrimidine
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 12 o3068
a=7.2346(12)Å b=22.585(3)Å c=8.0941(15)Å
α=90° β=106.177(17)° γ=90°
Piperidin-4-one
C22H27NO
Acta Crystallographica Section E (2009) 65, 12 o3083
a=12.2318(5)Å b=5.5879(2)Å c=26.9977(10)Å
α=90° β=94.377(3)° γ=90°
Piperidin-4-one
C19H19Cl2NO
Acta Crystallographica Section E (2008) 64, 12 o2312
a=13.1627(5)Å b=22.4739(7)Å c=5.8794(2)Å
α=90° β=90° γ=90°
Piperidin-4-one
C18H19NOS2,H2O
Acta Crystallographica Section E (2009) 65, 4 o885
a=7.5781(7)Å b=10.9926(9)Å c=11.5304(10)Å
α=79.531(2)° β=83.404(2)° γ=71.673(2)°
Methylcyclohepta[b]indole
C14H15NO
Acta Crystallographica Section E (2009) 65, 4 o698
a=9.6731(4)Å b=10.0924(5)Å c=11.8328(6)Å
α=90° β=103.397(5)° γ=90°
Pyrano[2,3-a]carbazol-2(11H)-one
C17H13NO2
Acta Crystallographica Section E (2009) 65, 4 o830
a=26.8502(4)Å b=6.82020(10)Å c=15.8265(3)Å
α=90° β=115.531(2)° γ=90°
Dihydropyrazine
C23H20N2
Acta Crystallographica Section E (2009) 65, 3 o546
a=10.4406(10)Å b=10.5753(7)Å c=11.0810(13)Å
α=93.439(8)° β=114.161(10)° γ=118.343(9)°